AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2013

Feb 13, 2013

Director's Dealing

Opens in your device viewer

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2013-02-12

Reporting Person: HALPRYN GLENN L (N/A)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-12	Common Stock	X	535714	$0.21	Acquired	1271428	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-12	Warrants to Purchase Common Stock	$0.21	X	535714	Disposed	2013-05-20	Common Stock (535714)	Indirect

F1: These Securities are held by IVC Investors, LLLP in which the Reporting Person has an interest.

F2: These disposed securities were held by IVC Investors, LLLP in which the Reporting Person has an interest.